UCB
A strategic Team Lead in New Product Planning for the Immunology space who drives early commercial strategy to maximize asset value. The role involves shaping indication strategies, translating market insights into Target Product Profiles, and leading a team of planners within a global biopharmaceutical organization.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
16% above the average for this role
Executive Director Global Product Lead Immunology Research And Development Cambridge Massachusetts United States Of America
AstraZeneca
Director, Competitive & Strategic Insights (CSI) - Oncology
AbbVie
Senior Director of New Product Planning
Moderna
Executive Director, Global Product Lead, Immunology Research and Development
AstraZeneca
Senior Director of New Product Planning
Moderna
New Product Planning Associate Director - Biopharma
Sumitomo Pharma America, Inc.